NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
No Result
View All Result
Home ALL Healthcare

endpoint and Berlinger Collaborate to Provide Complete Visibility of the Historical Temperature Journey of an IMP

by Ed Johnson
October 7, 2021
A A

Fully integrated solution: Turn a 25-day manual temperature-monitoring data evaluation into instant decision making

SAN FRANCISCO and SWITZERLAND, Oct. 6, 2021 — endpoint Clinical, the leader in global interactive response technology (IRT®) for clinical trials, and Berlinger & Co. AG, specializing in the production of innovative and customized solutions for monitoring temperature-sensitive goods in the pharmaceutical and medical industry, have announced their partnership to provide complete end to end visibility of the entire temperature history of an Investigational Medicinal Product (IMP). 

“Over the last several years, the cold chain logistics market for clinical trials has shown a growth of about 10%. This is largely related to the increasing number of biologicals and monoclonal antibodies that are under study. Therefore, cold chain failure in clinical trials has an increasing impact,” says Dr. Harald van Weeren, Segment Manager Clinical Trials at Berlinger.

Our organizations understand the risks of managing temperature-controlled IMP, and therefore, we focused on designing a solution to help reduce risk and eliminate the core issues. Such problems include limited transparency and missing information, the lack of immediate centralized visibility, time-consuming excursion management and slow decision making, time-consuming data consolidation for audits, wastage of drugs, and patient rescheduling or lost. 

Through this partnership, endpoint and Berlinger can provide Sponsors with a fully integrated solution, taking a 25-day manual temperature-monitoring data evaluation and turning it into instant decision making. This drastically reduces costs up to 7-digit figures and improves patient safety, allowing for fast decision-making through complete visibility of the temperature history. 

Sponsors and sites will reap immediate benefits through this sophisticated technology integration in a variety of areas:

  • Education: Less instruction needed for the site users
  • Handling: A reduction in admin time, manual handling, and associated risks
  • Excursion Management: Reduce the risk for dispensing drugs affected by a temperature deviation
  • Patient: Reduce failed patient visits and increase patient safety
  • Audit: All of the temperature data available in one system for easy preparation
  • Drugs: Reduce waste of trial products

“Patient safety has always been a high priority for endpoint.  As cold chain logistics become increasingly important due to the ever-growing number of studies that work with biologics, we understand how vital it is to maintain the chain of custody. This ensures that IMP does not go outside of agreed temperature ranges for that product. We are happy to be partnering with Berlinger on an integration providing a seamless solution for both the sponsor and site,” says Jeff Rubesin, Senior Director, Product Strategy at endpoint Clinical.

Tags: < Partnership
ShareTweetShareSend

Related Industries

Healthcare

Thermo Fisher Scientific Releases 2022 Corporate Social Responsibility Report

May 18, 2023
Healthcare

Oncotelic Participating at 2023 BIO International Convention

May 17, 2023
Healthcare

Medtronic AccuRhythm AI technology receives 2023 MedTech Breakthrough Award as Best New Monitoring Solution

May 17, 2023
Healthcare

Amgen Responds to Ftc Action RE: Proposed Acquisition Of Horizon Therapeutics

May 17, 2023
Healthcare

Cardinal Health Canada to open new distribution center in Ontario

May 11, 2023
Healthcare

Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access to Next Generation Sequencing-Based Testing for Cancer Patients in International Markets

May 10, 2023

Apple’s Worldwide Developers Conference to kick off June 5, 2023, with keynote address

May 24, 2023

...

Alstom and EDC enter into a strategic partnership for sustainable mobility financing

May 17, 2023

...

Apple announces multibillion-dollar deal with Broadcom for components made in the USA

May 24, 2023

...

Dow’s Seadrift, Texas location selected for X-energy advanced SMR nuclear project to deliver safe, reliable, zero carbon emissions power and steam production

May 12, 2023

...

IBM Unveils the Watsonx Platform to Power Next-Generation Foundation Models for Business

May 10, 2023

...

Oncotelic Participating at 2023 BIO International Convention

May 17, 2023

...

chevron announces agreement to acquire PDC energy

May 23, 2023

...

Gap Inc. Releases 2022 ESG Report, Sharing Progress On Sustainability And Inclusion

May 10, 2023

...

Blackstone Acquires International Gemological Institute (IGI)

May 22, 2023

...

NORTH AMERICAN BUSINESS (www.na-biz.com) is a leading source of business and corporate news, information, industry trends, market updates and insights across a broad spectrum of industries in North America and worldwide.

MENU

  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

CONTACT US

EDITORIAL:     editor#na-biz.com

PARTNERSHIP:     biz#na-biz.com

HUMAN RESOURCE:     hr#na-biz.com

* (replace # with @)

  • Official Site

Copyright © NA-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © NA-BIZ.COM All rights reserved.